Track topics on Twitter Track topics that are important to you
Professor Sir Munir Pirmohamed, from the University’s Institute of Translational Medicine, has been named as President Elect of the British Pharmacological Society for two years after which he will become President in 2020. The British Pharmacological Society is a charity with a mission to promote and advance the whole spectrum of pharmacology. The Society leads the way in the research and application of pharmacology around the world. Sir Munir, who is also Consultant Physician at the Royal Liverpool University Hospital, holds the only NHS Chair in Pharmacogenetics in the UK and is Director of the Medical Research Council’s Centre for Drug Safety Sciences. Personalised HealthcareHis research, which spans the whole spectrum from discovery to implementation, focuses on individual variability in drug response, including anti-cancer drugs, with a view to evaluating the mechanisms and identifying strategies to personalise healthcare.Of the award Sir Munir said: “I am honoured to have been elected to this prestigious position, and I am looking forward to playing such a significant role in promoting the BPS, its members and the field of pharmacological research around the world. “This honour not only recognises my work, but also the efforts of the whole team at the University of Liverpool. It is also further recognition of our Department of Molecular and Clinical Pharmacology, which was recently awarded the Queen’s Anniversary Prize.” The formal announcement of his appointment was made at the Society’s AGM on 12 December 2017, during its flagship annual meeting, Pharmacology 2017. ‘Ideal person’ Jonathan Bruun, Chief Executive of the Society, said: “I am delighted to see Munir elected to this role. For the past six years he has served the Society as Vice-President – Clinical, during which time he has led the campaign to build the profile of clinical pharmacology in the NHS. Munir’s track record of leadership on this issue and the high regard in which is he held in both medicine and academia – and by health policymakers – makes him the ideal person for this important position, and to take on the Presidency in two years’ time. “Munir is already one of our most authoritative and articulate advocates, and I look forward to working with him even more closely over the next two years.” To read more about Sir Munir’s research please visit https://www.liverpool.ac.uk/translational-medicine/staff/munir-pirmohamed/ or to listen to his podcast about personalised medicine visit here. For more information about The British Pharmacological Society please visit www.bps.ac.uk.NEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...